1. Home
  2. NRXS vs VVOS Comparison

NRXS vs VVOS Comparison

Compare NRXS & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXS
  • VVOS
  • Stock Information
  • Founded
  • NRXS 2011
  • VVOS 2016
  • Country
  • NRXS United States
  • VVOS United States
  • Employees
  • NRXS N/A
  • VVOS N/A
  • Industry
  • NRXS
  • VVOS Medical Specialities
  • Sector
  • NRXS
  • VVOS Health Care
  • Exchange
  • NRXS Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • NRXS 13.0M
  • VVOS 14.8M
  • IPO Year
  • NRXS 2023
  • VVOS 2020
  • Fundamental
  • Price
  • NRXS $2.49
  • VVOS $3.28
  • Analyst Decision
  • NRXS Strong Buy
  • VVOS Strong Buy
  • Analyst Count
  • NRXS 1
  • VVOS 2
  • Target Price
  • NRXS $7.00
  • VVOS $6.10
  • AVG Volume (30 Days)
  • NRXS 155.9K
  • VVOS 236.5K
  • Earning Date
  • NRXS 08-08-2025
  • VVOS 08-13-2025
  • Dividend Yield
  • NRXS N/A
  • VVOS N/A
  • EPS Growth
  • NRXS N/A
  • VVOS N/A
  • EPS
  • NRXS N/A
  • VVOS N/A
  • Revenue
  • NRXS $2,934,945.00
  • VVOS $14,628,000.00
  • Revenue This Year
  • NRXS $138,883.78
  • VVOS $17.40
  • Revenue Next Year
  • NRXS $118.59
  • VVOS $10.78
  • P/E Ratio
  • NRXS N/A
  • VVOS N/A
  • Revenue Growth
  • NRXS 27.52
  • VVOS 9.47
  • 52 Week Low
  • NRXS $1.33
  • VVOS $1.97
  • 52 Week High
  • NRXS $6.20
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • NRXS 49.91
  • VVOS 70.72
  • Support Level
  • NRXS $2.33
  • VVOS $2.03
  • Resistance Level
  • NRXS $2.67
  • VVOS $3.91
  • Average True Range (ATR)
  • NRXS 0.17
  • VVOS 0.26
  • MACD
  • NRXS -0.01
  • VVOS 0.13
  • Stochastic Oscillator
  • NRXS 46.43
  • VVOS 66.49

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: